These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 14598737

  • 1. [Cytokines and other signal molecules in the pathogenesis of acute pancreatitis].
    Shabanov VV.
    Vestn Ross Akad Med Nauk; 2003; (9):44-7. PubMed ID: 14598737
    [No Abstract] [Full Text] [Related]

  • 2. Cytokines and acute pancreatitis.
    Brady M, Christmas S, Sutton R, Neoptolemos J, Slavin J.
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Jul; 13(2):265-89. PubMed ID: 11030606
    [Abstract] [Full Text] [Related]

  • 3. A novel role for leucocytes in determining the severity of acute pancreatitis.
    Mayerle J.
    Gut; 2009 Nov; 58(11):1440-1. PubMed ID: 19834113
    [No Abstract] [Full Text] [Related]

  • 4. Lexipafant in severe acute pancreatitis: the final word?
    Ulrich CD.
    Curr Gastroenterol Rep; 2001 Apr; 3(2):85-7. PubMed ID: 11276374
    [No Abstract] [Full Text] [Related]

  • 5. The use of lexipafant in the treatment of acute pancreatitis.
    McKay C, Curran FJ, Sharples CE, Young CA, Baxter JN, Imrie CW.
    Adv Exp Med Biol; 1996 Apr; 416():365-70. PubMed ID: 9131175
    [Abstract] [Full Text] [Related]

  • 6. Multimodal management - of value in fulminant acute pancreatitis?
    Haraldsen P, Sun ZW, Börjesson A, Olanders K, Lasson A, Andersson R.
    Pancreatology; 2003 Apr; 3(1):14-25. PubMed ID: 12649560
    [Abstract] [Full Text] [Related]

  • 7. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis.
    Wang X, Sun Z, Börjesson A, Haraldsen P, Aldman M, Deng X, Leveau P, Andersson R.
    Int J Pancreatol; 1999 Feb; 25(1):45-52. PubMed ID: 10211421
    [Abstract] [Full Text] [Related]

  • 8. Cytokines in acute pancreatitis--new pathophysiological concepts evolve.
    Schmid RM, Adler G.
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):125-7. PubMed ID: 10102222
    [No Abstract] [Full Text] [Related]

  • 9. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis.
    Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP, McKay C, Toh SK, Skaife P, Leeder PC, Wilson P, Larvin M, Curtis LD.
    Gut; 2001 Jan; 48(1):62-9. PubMed ID: 11115824
    [Abstract] [Full Text] [Related]

  • 10. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.
    Leveau P, Wang X, Sun Z, Börjesson A, Andersson E, Andersson R.
    Biochem Pharmacol; 2005 May 01; 69(9):1325-31. PubMed ID: 15826603
    [Abstract] [Full Text] [Related]

  • 11. Recent developments in the management of acute pancreatitis.
    McKay CJ.
    Dig Surg; 2002 May 01; 19(2):129-34. PubMed ID: 11979001
    [No Abstract] [Full Text] [Related]

  • 12. [Conservative treatment of acute pancreatitis].
    Mayerle J, Simon P, Kraft M, Meister T, Lerch MM.
    Med Klin (Munich); 2003 Dec 15; 98(12):744-9. PubMed ID: 14685675
    [Abstract] [Full Text] [Related]

  • 13. The scientific basis of medical therapy of acute pancreatitis. Could it work, and is there a role for lexipafant?
    Imrie CW, McKay CJ.
    Gastroenterol Clin North Am; 1999 Sep 15; 28(3):591-9, ix. PubMed ID: 10503138
    [Abstract] [Full Text] [Related]

  • 14. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis.
    Lane JS, Todd KE, Gloor B, Chandler CF, Kau AW, Ashley SW, Reber HA, McFadden DW.
    J Surg Res; 2001 Aug 15; 99(2):365-70. PubMed ID: 11469912
    [Abstract] [Full Text] [Related]

  • 15. Hope or hype for lexipafant?
    Abu-Zidan FM.
    Nature; 1998 Oct 01; 395(6701):431. PubMed ID: 9774090
    [No Abstract] [Full Text] [Related]

  • 16. [New aspects of pharmaco-therapy for acute pancreatitis].
    Takase K, Ueda T, Kuroda Y.
    Nihon Rinsho; 2004 Nov 01; 62(11):2074-8. PubMed ID: 15552891
    [Abstract] [Full Text] [Related]

  • 17. Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials.
    Abu-Zidan FM, Windsor JA.
    Eur J Surg; 2002 Nov 01; 168(4):215-9. PubMed ID: 12440758
    [Abstract] [Full Text] [Related]

  • 18. Platelet-activating factor.
    Kingsnorth AN.
    Scand J Gastroenterol Suppl; 1996 Nov 01; 219():28-31. PubMed ID: 8865468
    [Abstract] [Full Text] [Related]

  • 19. The potential role of therapeutic cytokine manipulation in acute pancreatitis.
    Denham W, Norman J.
    Surg Clin North Am; 1999 Aug 01; 79(4):767-81. PubMed ID: 10470326
    [Abstract] [Full Text] [Related]

  • 20. Cytokine storm in acute pancreatitis.
    Makhija R, Kingsnorth AN.
    J Hepatobiliary Pancreat Surg; 2002 Aug 01; 9(4):401-10. PubMed ID: 12483260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.